169 related articles for article (PubMed ID: 33795649)
1. SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance.
Li J; Wu R; Yung MMH; Sun J; Li Z; Yang H; Zhang Y; Liu SS; Cheung ANY; Ngan HYS; Braisted JC; Zheng W; Wei H; Gao Y; Nemes P; Pei H; Chan DW; Li Y; Zhu W
Cell Death Dis; 2021 Apr; 12(4):341. PubMed ID: 33795649
[TBL] [Abstract][Full Text] [Related]
2. Identification of potent SENP1 inhibitors that inactivate SENP1/JAK2/STAT signaling pathway and overcome platinum drug resistance in ovarian cancer.
Zhang Y; Wei H; Zhou Y; Li Z; Gou W; Meng Y; Zheng W; Li J; Li Y; Zhu W
Clin Transl Med; 2021 Dec; 11(12):e649. PubMed ID: 34954894
[No Abstract] [Full Text] [Related]
3. Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
Zhou W; Sun W; Yung MMH; Dai S; Cai Y; Chen CW; Meng Y; Lee JB; Braisted JC; Xu Y; Southall NT; Shinn P; Huang X; Song Z; Chen X; Kai Y; Cai X; Li Z; Hao Q; Cheung ANY; Ngan HYS; Liu SS; Barak S; Hao J; Dai Z; Tzatsos A; Peng W; Pei H; Han Z; Chan DW; Zheng W; Zhu W
Oncogene; 2018 Jul; 37(29):3981-3997. PubMed ID: 29662190
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
Wei H; Guo J; Sun X; Gou W; Ning H; Shang H; Liu Q; Hou W; Li Y
J Nat Prod; 2022 May; 85(5):1248-1255. PubMed ID: 35500202
[TBL] [Abstract][Full Text] [Related]
5. SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis.
Li X; Luo Y; Yu L; Lin Y; Luo D; Zhang H; He Y; Kim YO; Kim Y; Tang S; Min W
Cell Death Differ; 2008 Apr; 15(4):739-50. PubMed ID: 18219322
[TBL] [Abstract][Full Text] [Related]
6. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1.
Kim YH; Sung KS; Lee SJ; Kim YO; Choi CY; Kim Y
FEBS Lett; 2005 Nov; 579(27):6272-8. PubMed ID: 16253240
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells.
Xu Y; Zhang J; Wu J; Zhong S; Li H
Int J Gynecol Cancer; 2015 Nov; 25(9):1557-64. PubMed ID: 26360705
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells.
Park GB; Kim D
Neoplasia; 2019 Feb; 21(2):206-215. PubMed ID: 30622051
[TBL] [Abstract][Full Text] [Related]
9. SENP1 participates in Irinotecan resistance in human colon cancer cells.
Chen MC; Nhan DC; Hsu CH; Wang TF; Li CC; Ho TJ; Mahalakshmi B; Chen MC; Yang LY; Huang CY
J Cell Biochem; 2021 Oct; 122(10):1277-1294. PubMed ID: 34037277
[TBL] [Abstract][Full Text] [Related]
10. Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.
Wei J; Wang H; Zheng Q; Zhang J; Chen Z; Wang J; Ouyang L; Wang Y
Eur J Med Chem; 2022 Nov; 241():114650. PubMed ID: 35939992
[TBL] [Abstract][Full Text] [Related]
11. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation.
Wu J; Lei H; Zhang J; Chen X; Tang C; Wang W; Xu H; Xiao W; Gu W; Wu Y
Oncotarget; 2016 Sep; 7(37):58995-59005. PubMed ID: 27449295
[TBL] [Abstract][Full Text] [Related]
12. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
[TBL] [Abstract][Full Text] [Related]
13. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α.
Ao Q; Su W; Guo S; Cai L; Huang L
Sci Rep; 2015 Nov; 5():16396. PubMed ID: 26548925
[TBL] [Abstract][Full Text] [Related]
14. Involvement of nuclear JAK2 signaling in AG490-induced apoptosis of gastric cancer cells.
Qian C; Wang J; Yao J; Wang L; Xue M; Liu W; Si J
Anat Rec (Hoboken); 2013 Dec; 296(12):1865-73. PubMed ID: 24151255
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation is a regulator of the translocation of Jak2 between nucleus and cytosol.
Sedek M; Strous GJ
Biochem J; 2013 Jul; 453(2):231-9. PubMed ID: 23581279
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of JAK2/STAT3 and activation of caspase‑9/3 are involved in KYS05090S‑induced apoptosis in ovarian cancer cells.
Kim BI; Kim JH; Sim DY; Nam M; Jung JH; Shim B; Lee J; Kim SH
Int J Oncol; 2019 Jul; 55(1):203-210. PubMed ID: 31059018
[TBL] [Abstract][Full Text] [Related]
17. Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis.
Dalagiorgou G; Piperi C; Adamopoulos C; Georgopoulou U; Gargalionis AN; Spyropoulou A; Zoi I; Nokhbehsaim M; Damanaki A; Deschner J; Basdra EK; Papavassiliou AG
Cell Mol Life Sci; 2017 Mar; 74(5):921-936. PubMed ID: 27699453
[TBL] [Abstract][Full Text] [Related]
18. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
[TBL] [Abstract][Full Text] [Related]
19. The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis.
Qiu C; Wang Y; Zhao H; Qin L; Shi Y; Zhu X; Song L; Zhou X; Chen J; Zhou H; Zhang H; Tellides G; Min W; Yu L
Nat Commun; 2017 Jun; 8():15426. PubMed ID: 28569748
[TBL] [Abstract][Full Text] [Related]
20. Nuclear JAK2: form and function in cancer.
Qian CJ; Yao J; Si JM
Anat Rec (Hoboken); 2011 Sep; 294(9):1446-59. PubMed ID: 21809458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
